$2.33T
Total marketcap
$90.87B
Total volume
BTC 49.98%     ETH 15.45%
Dominance

Nextgen Biomed Ltd NXGN.TA Stock

109 ILA {{ price }} -2.417186% {{change_pct}}%
COUNTRY
Israel
Exchange
Tel Aviv
Market Cap
8.51M ILA
LOW - HIGH [24H]
111 - 124.5 ILA
VOLUME [24H]
3.7K ILA
{{ volume }}
P/E Ratio
0
Earnings per share
-1.55 ILA

Nextgen Biomed Ltd Price Chart

Nextgen Biomed Ltd NXGN.TA Financial and Trading Overview

Nextgen Biomed Ltd stock price 109 ILA
Previous Close 50.6 ILA
Open 50.6 ILA
Bid 51.7 ILA x N/A
Ask 53 ILA x N/A
Day's Range 50.6 - 53 ILA
52 Week Range 45.1 - 177.9 ILA
Volume 39.29K ILA
Avg. Volume 28.73K ILA
Market Cap 22.67M ILA
Beta (5Y Monthly) 1.14315
PE Ratio (TTM) N/A
EPS (TTM) -1.55 ILA
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

NXGN.TA Valuation Measures

Enterprise Value 16.58M ILA
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 183.50877
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -4.64

Trading Information

Nextgen Biomed Ltd Stock Price History

Beta (5Y Monthly) 1.14315
52-Week Change -48.55%
S&P500 52-Week Change 20.43%
52 Week High 177.9 ILA
52 Week Low 45.1 ILA
50-Day Moving Average 57.17 ILA
200-Day Moving Average 69.82 ILA

NXGN.TA Share Statistics

Avg. Volume (3 month) 28.73K ILA
Avg. Daily Volume (10-Days) 31.7K ILA
Shares Outstanding 43.35M
Float 37.08M
Short Ratio N/A
% Held by Insiders 11.90%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:25

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -11.62%
Return on Equity (ttm) -52.20%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -3574000 ILA
Net Income Avi to Common (ttm) -8572000 ILA
Diluted EPS (ttm) -0.19
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 5.24M ILA
Total Cash Per Share (mrq) 0.12 ILA
Total Debt (mrq) 0 ILA
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 4.172
Book Value Per Share (mrq) 0.285

Cash Flow Statement

Operating Cash Flow (ttm) -2753000 ILA
Levered Free Cash Flow (ttm) -1372125 ILA

Profile of Nextgen Biomed Ltd

Country Israel
State N/A
City Tel Aviv
Address 132 Azrieli Towers Round Building
ZIP 6701101
Phone 972 9 950 0555
Website https://www.nextgen-biomed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 15

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

Q&A For Nextgen Biomed Ltd Stock

What is a current NXGN.TA stock price?

Nextgen Biomed Ltd NXGN.TA stock price today per share is 109 ILA.

How to purchase Nextgen Biomed Ltd stock?

You can buy NXGN.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Nextgen Biomed Ltd?

The stock symbol or ticker of Nextgen Biomed Ltd is NXGN.TA.

Which industry does the Nextgen Biomed Ltd company belong to?

The Nextgen Biomed Ltd industry is Medical Instruments & Supplies.

How many shares does Nextgen Biomed Ltd have in circulation?

The max supply of Nextgen Biomed Ltd shares is 78.03K.

What is Nextgen Biomed Ltd Price to Earnings Ratio (PE Ratio)?

Nextgen Biomed Ltd PE Ratio is now.

What was Nextgen Biomed Ltd earnings per share over the trailing 12 months (TTM)?

Nextgen Biomed Ltd EPS is -1.55 ILA over the trailing 12 months.

Which sector does the Nextgen Biomed Ltd company belong to?

The Nextgen Biomed Ltd sector is Healthcare.